Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ulrich-Peter Rohr

3PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 01, 2026
Review Duration and Therapeutic Value of Cancer Drugs Granted Priority Versus Nonpriority Review in the United States, European Union, and Switzerland (2010-2024).

Simon Hediger, Lara Welti, Camille E G Glaus

|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser

|Oct 16, 2023
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020.

Kerstin N Vokinger, Miquel Serra-Burriel, Camille E G Glaus

Pageof 1

Frequent Collaborators

2 joint publications

Kerstin Noelle Vokinger

1 joint publications

Miquel Serra-Burriel

1 joint publications

Simon Dalla Torre di Sanguinetto

1 joint publications

Aaron S Kesselheim

1 joint publications

Francesco Pignatti

1 joint publications

Tarec Christoffer El-Galaly

1 joint publications

Martin Kaiser

1 joint publications

Kimmo Porkka

1 joint publications

Robin Doeswijk

1 joint publications

Peter Mol

Frequent Collaborators

2 joint publications

Kerstin Noelle Vokinger

1 joint publications

Miquel Serra-Burriel

1 joint publications

Simon Dalla Torre di Sanguinetto

1 joint publications

Aaron S Kesselheim

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

28.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

926
A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on : Jul 14, 2023

2.0K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

28.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

926
A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on : Jul 14, 2023

2.0K
See more related videos